Archive for May, 2009
Results from an international, placebo-controlled trial,1 presented for the first time at the American Academy of Neurology (AAN) Annual Meeting in Seattle, U.S.A. demonstrate that Mirapexin® / Sifrol® (pramipexole) also improves depressive symptoms, a common, disabling non-motor symptom of Parkinson`s disease (PD), in addition to its established efficacy in treating the motor symptoms of PD.
The "PD-depression" Read the rest of this entry »
Data unveiled today at the American Society of Hypertension’s Twenty Fourth Annual Scientific Meeting (ASH 2009) demonstrate that, while receiving Web-based pharmacist care, patients with hypertension are more engaged and no less satisfied with their care than when receiving usual care. They initiate more contact with their physician and are no less satisfied with their primary care team despite the lack of traditional face-to-face Read the rest of this entry »
May
28
A high salt intake has been implicated in cardiovascular disease risk for 5000 years. But salt-sensitive hypertension still remains an enigma. Now, investigators from Germany at the University of Erlangen, the Max Delbr??ck Center for Molecular Medicine (MDC) Berlin-Buch and Regensburg, collaborating with researchers from Finland and Austria have shed new light on the relationship between salt intake, bodily processes, Read the rest of this entry »
While a person may not seem emotionally or psychologically troubled in the immediate aftermath of a traumatic event, symptoms of posttraumatic stress disorder (PTSD) can surface up to two years following an event for those with pre-existing emotional or social problems.
That is the main conclusion of new Geisinger-led research that examined the onset and development of PTSD. The study appears in the electronic edition of the research journal Read the rest of this entry »
New antidepressants might be no more effective than the best existing drugs, according to two new systematic reviews that compared 12 commonly used medications.
"Patients are usually encouraged to take the newest medication," said lead author Andrea Cipriani, M.D., of Read the rest of this entry »